Patrick Selosse

Title: Patrick Selosse: Innovator in Virus-Inactivated Immunoglobulin Solutions

Introduction

Patrick Selosse is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of immunology through his innovative work. His expertise is particularly evident in the development of processes that enhance the safety and efficacy of immunoglobulin solutions.

Latest Patents

Patrick Selosse holds a patent for a "Process for preparing virus-inactivated immunoglobulin solutions." This invention describes a method for preparing immunoglobulin solutions that are safe for intravenous application. The process involves treating immunoglobulin with non-ionic surfactants, which are subsequently removed through solid-phase extraction on hydrophobic materials. This innovative approach ensures that the immunoglobulin solutions are free from viral contaminants, thereby enhancing patient safety.

Career Highlights

Patrick Selosse is associated with Octapharma AG, a company known for its commitment to developing high-quality human proteins. His work at Octapharma AG has been instrumental in advancing therapeutic solutions that address various medical needs. With a focus on patient safety and product efficacy, Selosse has contributed to the company's reputation as a leader in the field.

Collaborations

Patrick Selosse collaborates with Werner Gehringer, a fellow innovator in the field. Their partnership exemplifies the importance of teamwork in driving advancements in medical technology.

Conclusion

Patrick Selosse's contributions to the field of immunology, particularly through his patented process for preparing virus-inactivated immunoglobulin solutions, highlight his role as a key innovator. His work not only enhances the safety of medical treatments but also reflects the ongoing commitment to improving patient care.